Infectious uveitis is a sight-threatening inflammatory condition affecting the uvea, the middle layer of the eye, and is caused by various infectious agents. Bacterial, viral, fungal, and parasitic infections can lead to uveitis, triggering inflammation and potentially causing long-term damage to ocular structures. Common pathogens associated with infectious uveitis include herpes simplex virus, cytomegalovirus, toxoplasma, tuberculosis, and syphilis. These infections can manifest with symptoms such as eye pain, redness, blurred vision, and sensitivity to light. Diagnosis involves a thorough examination, including laboratory tests, imaging studies, and sometimes ocular fluid analysis to identify the causative agent. Prompt and targeted treatment with antimicrobial agents is essential to control the infection and prevent complications. Complications of infectious uveitis may include glaucoma, cataracts, and retinal damage. Chronic inflammation can lead to vision impairment or even blindness if left untreated. Management requires a multidisciplinary approach involving ophthalmologists and infectious disease specialists, and follow-up care is crucial for monitoring and preventing recurrence. Early detection, accurate diagnosis, and timely intervention are critical in preserving visual function and improving outcomes for individuals with infectious uveitis.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia